A Study to Find Out if Fezolinetant Helps Reduce Moderate to Severe Hot Flashes in Women in Asia Going Through Menopause
Clinical trial NCT04234204 · COMPLETED
Trial details
- NCT number
- NCT04234204
- Sponsor
- Astellas Pharma China, Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-03-17
- Primary completion
- 2022-04-20
- Enrollment
- 302
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.